Hewlett-Packard Company (HPQ), Sony Corporation (ADR) (SNE): Can These Companies Continue Their Bull Run?

Page 1 of 2

When the stock price of a company increases significantly, investors are curious to know whether it is likely to increase further. High growth in a short time might make investors skeptical about further growth potential of the stock. However, there are some stocks which have further growth potential. Here are three companies that have registered more than 70% YTD growth in their stock prices.

Source: Google Finance

In order to maintain this high-growth trajectory, these companies are releasing new products. Let’s have a look at these products and the growth opportunities for each company.

A company being made to sweat

Hewlett-Packard Company (NYSE:HPQ) launched Moonshot servers in April 2013 in the U.S. and Canada. This server consumes 89% less energy and is 77% cheaper than a traditional server. The Moonshot server is a part of HP’s commodity server business, or CSB. The company launched these servers to revive its distressed CSB. However, Moonshot failed to have the expected impact on CSB. The company’s CSB segment posted revenue of $3.04 billion in the second-quarter of 2013, a decrease of 12% year-over-year.

Hewlett-Packard Company (NYSE:HPQ)

Hewlett-Packard Company (NYSE:HPQ) is also facing severe challenges in its personal computer, or PC, segment. Its PC segment revenue dropped 20% year-over-year in the second-quarter of 2013. Despite being a market leader in the PC segment, it is continuously losing its market share to its competitor, Lenovo. In the second quarter of 2012, Hewlett-Packard Company (NYSE:HPQ) had 17.8% market share in the PC business as compared to Lenovo’s 13.2%. However, it now has 15.7% market share, and Lenovo occupies 15.3% of the PC market.

Credit: Hewlett-Packard Company (NYSE:HPQ)

A company launching a smartphone

Sony Corporation (ADR) (NYSE:SNE) is expected to launch its latest smartphone Xperia Z Ultra in July 2013. It is believed to be the best smartphone Sony has ever made. The Xperia Z Ultra has a 32,173 point AnTuTu score, and beats its peer, Samsung Galaxy S4, by almost 700 points. AnTuTu score is a benchmark for smartphones.

The Xperia Z Ultra will be carried exclusively by T MOBILE US INC (NYSE: TMUS) in the U.S. T-Mobile offers a “simple choice plan” to its customers. This plan allows the customers to design their plan based on the number of lines and amount of high-speed data they want. T MOBILE US INC will allow Xperia Z Ultra users to connect to its high-speed 4G network across the U.S. This network is expected to reach 100 million people in June and 200 million people by the end of this year. Therefore, it will increase Sony’s addressable market in the U.S. significantly.

Both Sony Corporation (ADR) (NYSE:SNE) and Microsoft Corporation (NASDAQ:MSFT) revealed their latest gaming consoles in June 2013. Microsoft introduced Xbox One, scheduled to be launched in the market in early November this year. Sony revealed its PlayStation 4, or PS4, that is likely to hit the markets in late November.

PS4 is attractively priced at $399, $100 less than its rival Xbox One. Analysts believe that the PS4 will be a game changer for Sony Corporation (ADR) (NYSE:SNE) because of its pro-consumer features as compared to the Xbox One. Amazon.com, Inc. (NASDAQ:AMZN) conducted a poll asking consumers whether they preferred the PS4 or the Xbox One. PS4 won the poll with 38,984 consumers voting for PS4, whereas Xbox One managed a mere 2,162 votes. Sony sold 70 million-75 million units of PS3 in the last few years. If sales remain similar, yearly sales of 12 million PS4 units can be expected. This will help Sony Corporation (ADR) (NYSE:SNE) generate yearly revenue of $4.99 billion from PS4.

A pharma giant testing drugs

In February 2013, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced plans to conduct phase 3 studies to test its drug VX-809 combined with another drug, Ivacaftor. These two drugs cure cystic fibrosis, or CF. CF is a life-shortening disease that causes lung dysfunction.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) plans to conduct phase 3 studies in two stages of 24 weeks each. On successful completion of the studies, the company will apply for drug approval to the FDA and the European Medicines Agency.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The Top 10 States With Fastest Internet Speeds

10 Best Places to Visit in USA in August

Top 10 Cities to Visit Before You Die

Top 10 Genetically Modified Food In the US

15 Highest Grossing Movies Opening Weekend

5 Best Poker Books For Beginners

10 Strategies Hedge Funds Use to Make Huge Returns

Top 10 Fast Food Franchises to Buy

10 Best Places to Visit in Canada

Best Summer Jobs for Teachers

10 Youngest Hedge Fund Billionaires

Top 10 One Hit Wonders of the 90s

Fastest Growing Cities In America

Top 10 U.S. Cities for Freelancers

Top 9 Most Popular Free iPhone Apps

Top 10 Least Expensive Private Business Schools in the US

Top 15 Most Expensive Countries in the World – 2014

Top Businesses to Invest In

Top 5 Things You Might Be Doing Wrong With Your Business

Top 5 Strategic Technology Trends in 2014

Top Rags to Riches Stories

Parenting Behavior That Promotes Future Leaders

Top 5 Mistakes Made by Small Businesses

Top 5 Most Common and Potentially Devastating Financial Blunders

Top 5 Highest Paying Jobs for Web Designers

Top 6 Most Respected Professions that Also Pay Well

Top 5 Pitfalls Investors Should Avoid

Top 6 Lawyers and Policy Makers Under 30

Top 6 New Year’s Resolutions for Entrepreneurs

Top 7 Locations to Check in on Facebook

Top 5 Mistakes made by Rookie eBay Sellers

Top 7 eBook Publishers in 2013

Top 6 Health Industry Trends in 2014

5 Lessons for Entrepreneurs from Seth Godin

Top 5 Success Tips from Jordan Belfort – the Wolf of Wall Street

Best Master’s in Finance Degree Programs

Top 6 Earning Celebrities Over 50

The most expensive sports to play

Top 7 Earning Celebrities Under 25

Best 7 Online Courses to Take: Free Finance MOOCs

Top 6 Bad Habits that Promote Failure

20 Most Valuable Soccer Teams in the World in 2013

12 Most Expensive Countries for Foreign Students

Top 30 Most Influential Women in the World

Top 20 Most Expensive New Year Eve Shows

Top 5 Best Vocational Careers

Top 10 Jobs for 2014 by Salary Gain (Predictions)

Top 5 Digital Trends for 2014

Top 6 Things You Can Do To Increase Your Productivity

Top 9 Trending Smartphones in 2013

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!